These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 660683)

  • 41. Principles of drug administration in renal insufficiency.
    Lam YW; Banerji S; Hatfield C; Talbert RL
    Clin Pharmacokinet; 1997 Jan; 32(1):30-57. PubMed ID: 9012555
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of computer-based alerts on the treatment and outcomes of hospitalized patients.
    Rind DM; Safran C; Phillips RS; Wang Q; Calkins DR; Delbanco TL; Bleich HL; Slack WV
    Arch Intern Med; 1994 Jul; 154(13):1511-7. PubMed ID: 8018007
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pregnancy and renal failure: the case for application of dosage guidelines.
    Keller F; Griesshammer M; Häussler U; Paulus W; Schwarz A
    Drugs; 2001; 61(13):1901-20. PubMed ID: 11708763
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Predicting the Effect of Renal Function on Systemic Clearance: Is a Simple Scaling Method Sufficient?
    McNamara PJ; Meiman D
    J Pharm Sci; 2023 Jun; 112(6):1724-1732. PubMed ID: 37023855
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The old and new methods of assessing kidney function.
    Steffl JL; Bennett W; Olyaei AJ
    J Clin Pharmacol; 2012 Jan; 52(1 Suppl):63S-71S. PubMed ID: 22232755
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function.
    De Vecchis R; Ciccarelli A; Ariano C; Cioppa C; Giasi A; Pucciarelli A; Cantatrione S
    Minerva Cardioangiol; 2011 Dec; 59(6):543-54. PubMed ID: 21330961
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of renal function on argatroban therapy in heparin-induced thrombocytopenia.
    Guzzi LM; McCollum DA; Hursting MJ
    J Thromb Thrombolysis; 2006 Dec; 22(3):169-76. PubMed ID: 17103051
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Use of recalibrated serum creatinine concentrations for adjustment of drug dosages: determination of values compatible with conventional dosing recommendations.
    Jones MA; Golightly LK; Stolpman NM
    Ann Pharmacother; 2011 Jun; 45(6):748-56. PubMed ID: 21666086
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Continuing the use of the Cockcroft-Gault equation for drug dosing in patients with impaired renal function.
    Spruill WJ; Wade WE; Cobb HH
    Clin Pharmacol Ther; 2009 Nov; 86(5):468-70. PubMed ID: 19844221
    [No Abstract]   [Full Text] [Related]  

  • 50. Renal dosing in high-risk populations.
    Nyman HA
    J Infus Nurs; 2015; 38(3):210-5. PubMed ID: 25871868
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Carbenicillin therapy in patients with normal and impaired renal function.
    Latos DL; Bryan CS; Stone WJ
    Clin Pharmacol Ther; 1975 Jun; 17(6):692-700. PubMed ID: 1139860
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluation of renal drug dosing: prescribing information and clinical pharmacist approaches.
    Dowling TC; Matzke GR; Murphy JE; Burckart GJ
    Pharmacotherapy; 2010 Aug; 30(8):776-86. PubMed ID: 20653353
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clearance of vancomycin during continuous infusion in Intensive Care Unit patients: correlation with measured and estimated creatinine clearance and serum cystatin C.
    Kees MG; Hilpert JW; Gnewuch C; Kees F; Voegeler S
    Int J Antimicrob Agents; 2010 Dec; 36(6):545-8. PubMed ID: 20863668
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of chronic renal failure on the disposition of highly hepatically metabolized drugs.
    Yuan R; Venitz J
    Int J Clin Pharmacol Ther; 2000 May; 38(5):245-53. PubMed ID: 10839468
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Validity of creatinine clearance estimates in the assessment of renal function.
    Luke DR; Halstenson CE; Opsahl JA; Matzke GR
    Clin Pharmacol Ther; 1990 Nov; 48(5):503-8. PubMed ID: 2225710
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Drug dosage in patients with impaired renal function.
    Dettli L; Spring P; Habersang R
    Postgrad Med J; 1970 Oct; ():Suppl:32-5. PubMed ID: 5488205
    [No Abstract]   [Full Text] [Related]  

  • 57. Nesiritide does not improve renal function in patients with chronic heart failure and worsening serum creatinine.
    Wang DJ; Dowling TC; Meadows D; Ayala T; Marshall J; Minshall S; Greenberg N; Thattassery E; Fisher ML; Rao K; Gottlieb SS
    Circulation; 2004 Sep; 110(12):1620-5. PubMed ID: 15337695
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Assessment of adherence to renal dosing guidelines in long-term care facilities.
    Papaioannou A; Clarke JA; Campbell G; Bédard M
    J Am Geriatr Soc; 2000 Nov; 48(11):1470-3. PubMed ID: 11083325
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Renal drug dosing recommendations: evaluation of product information for brands of the same drug.
    Khanal A; Peterson GM; Castelino RL; Jose MD
    Intern Med J; 2014 Jun; 44(6):591-6. PubMed ID: 24946814
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Incidence of renal insufficiency in cancer patients and evaluation of information available on the use of anticancer drugs in renally impaired patients.
    Launay-Vacher V; Izzedine H; Rey JB; Rixe O; Chapalain S; Nourdine S; Paci A; Bourget P; Deray G
    Med Sci Monit; 2004 May; 10(5):CR209-12. PubMed ID: 15114271
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.